sofosbuvir
Phase 3- Indications
- Hepatitis C
Company intelligence / Profile preview
Pharmasset Inc.
Princeton, New Jersey, United Statesen.wikipedia.org ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Phase 3
01
Overview
Pharmasset was a clinical-stage pharmaceutical company focused on developing oral antiviral therapeutics for hepatitis C. Its lead compound, PSI‑7977, showed strong efficacy and safety in Phase II studies and entered multiple Phase III trials targeting different HCV genotypes. The company also had additional nucleotide analogs in its pipeline for HCV and partnered with Roche on mericitabine. Gilead acquired Pharmasset to accelerate the development of all‑oral regimens for HCV treatment[1][6][7].
- Therapeutic areas
- Infectious Diseases
- Modalities
- small molecules (nucleoside/nucleotide analogs)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Roche – co-development of mericitabine/RG7128[7].
Beyond the preview
Go deeper on Pharmasset Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmasset Inc..